EA202090415A1 - ANTI-CD47 ANTIBODIES AND THEIR APPLICATION - Google Patents
ANTI-CD47 ANTIBODIES AND THEIR APPLICATIONInfo
- Publication number
- EA202090415A1 EA202090415A1 EA202090415A EA202090415A EA202090415A1 EA 202090415 A1 EA202090415 A1 EA 202090415A1 EA 202090415 A EA202090415 A EA 202090415A EA 202090415 A EA202090415 A EA 202090415A EA 202090415 A1 EA202090415 A1 EA 202090415A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- antibodies
- disease
- application
- arteriosclerosis
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Описаны анти-CD47 антитела и антигенсвязывающие фрагменты. Также описаны нуклеиновые кислоты, кодирующие эти антитела, композиции, содержащие антитела, и способы получения антител и применения антител для лечения или профилактики заболеваний, таких как злокачественная опухоль, воспалительное заболевание, инфекционное заболевание, артериосклероз, сердечно-сосудистое заболевание, нарушения метаболизма, радиационное поражение и/или аутоиммунное заболевание.Anti-CD47 antibodies and antigen binding fragments are described. Also described are nucleic acids encoding these antibodies, compositions containing antibodies, and methods for producing antibodies and using antibodies for treating or preventing diseases such as a malignant tumor, inflammatory disease, infectious disease, arteriosclerosis, cardiovascular disease, metabolic disorders, radiation damage and / or autoimmune disease.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862657094P | 2018-04-13 | 2018-04-13 | |
PCT/US2018/044384 WO2019027903A1 (en) | 2017-08-02 | 2018-07-30 | Anti-cd47 antibodies and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202090415A1 true EA202090415A1 (en) | 2020-06-02 |
Family
ID=71138829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202090415A EA202090415A1 (en) | 2018-04-13 | 2018-07-30 | ANTI-CD47 ANTIBODIES AND THEIR APPLICATION |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA202090415A1 (en) |
-
2018
- 2018-07-30 EA EA202090415A patent/EA202090415A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202004730B (en) | Anti-claudin 18.2 antibodies and uses thereof | |
ZA202000373B (en) | Anti-cd47 antibodies and uses thereof | |
MX2020009366A (en) | Anti-cd73 antibodies and uses thereof. | |
MX2022015901A (en) | Bispecific binding proteins and uses thereof. | |
PH12020551211A1 (en) | Antibodies binding to gprc5d | |
MY194642A (en) | Antibodies binding to cd3 | |
PH12020552010A1 (en) | Anti-cd33 antibodies, anti-cd33/anti-cd3 bispecific antibodies and uses thereof | |
UA120060C2 (en) | Cd123 binding agents and uses thereof | |
MX2022001156A (en) | Antibodies binding to gprc5d. | |
EA201890796A1 (en) | NEW ANTIBODY TO MEZOTHELIN AND THE CONTENTS OF IT | |
TN2018000325A1 (en) | ANTl-CD3 ANTIBODIES, ANTl-CD123 ANTIBODIES AND BISPECIFIC ANTIBODIES SPECIFICALL Y BINDING TO CD3 AND/OR CD123. | |
EA201790755A1 (en) | MODULATION OF STIMULATING AND NONSTIMULATING MYELOID CELLS | |
EA201990321A1 (en) | BISPECIFIC ANTI-CURRENT BINDING PROTEINS THAT SPECIFICALLY BIND TO CD3 AND CD123 | |
EA202090401A1 (en) | ANTI-TIM-3 ANTIBODIES AND THEIR APPLICATION | |
MY200162A (en) | Anti-gitr antibodies and uses thereof | |
MX2020011914A (en) | Anti-dll3 antibodies and uses thereof. | |
EA201990218A1 (en) | ANTIBODIES WITH LOW IMMUNOGENITY AND THEIR APPLICATION | |
MX2021004454A (en) | Anti-synuclein antibodies. | |
WO2019122052A3 (en) | Antibodies binding to hla-a2/wt1 | |
PH12019502274A1 (en) | Antibodies binding to steap-1 | |
MX2022010664A (en) | Materials and methods for modulating an immune response. | |
EA202191658A1 (en) | ANTIBODIES AGAINST HUMAN COMPLETE FACTOR C2B AND METHODS OF APPLICATION | |
EA202090415A1 (en) | ANTI-CD47 ANTIBODIES AND THEIR APPLICATION | |
JOP20210297A1 (en) | Materials and methods for modulating t cell mediated immunity | |
MX2022013920A (en) | Anti-tumor associated antigen antibodies and uses thereof. |